EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy

Martina Paoletti, Chiara Bini, Andrea Marcellusi, Francesco Saverio Mennini

Clinical Drug Investigation · 2024

DOI: 10.1007/s40261-024-01366-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Martina Paoletti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy. mart.paoletti@…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Antibodies, Monoclonal, Humanized, Melanoma, Lung Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Roma Tor Vergata.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungAntibodies, Monoclonal, HumanizedMelanomaLung NeoplasmsCost-Benefit AnalysisQuality-Adjusted Life YearsHumansItalyAntineoplastic Agents, ImmunologicalModels, Economic

Substanzen

pembrolizumabAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy. mart.paoletti@gmail.com.
  • Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy.
  • Institute for Leadership and Management in Health, Kingston University London, London, UK.

Förderung

  • Università degli Studi di Roma Tor Vergata

Zitieren

APA

Paoletti, M., Bini, C., Marcellusi, A., & Mennini, F. S. (2024). Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01366-y

Vancouver

Paoletti M, Bini C, Marcellusi A, Mennini FS. Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy. Clinical Drug Investigation. 2024. doi:10.1007/s40261-024-01366-y

BibTeX
@article{Paoletti2024,
  author = {Paoletti, Martina and Bini, Chiara and Marcellusi, Andrea and Mennini, Francesco Saverio},
  title = {Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy},
  journal = {Clinical Drug Investigation},
  year = {2024},
  doi = {10.1007/s40261-024-01366-y}
}
Kostenlos starten →